Project Sueño: Sleep & Understanding Early Nutrition in Obesity
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Nov 1, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial called "Project Sueño" is focused on understanding how mothers feel about feeding and putting their babies to sleep. The goal is to learn more about how to best support mothers in caring for their infants, especially to help prevent obesity and related health issues as their children grow. The study specifically aims to help mothers of young babies, particularly those from Latino or Hispanic backgrounds, make informed decisions about their baby's nutrition and sleep habits to promote healthy growth.
To participate in this study, mothers need to have a healthy baby who is less than one month old and was born full term (after 37 weeks of pregnancy). The mothers should be at least 18 years old and willing to attend follow-up visits for the study. However, mothers who smoke, work mostly at night, or have infants with certain health issues cannot join. Participants can expect to share their experiences and receive support, ultimately helping to improve care for their children and reduce the risk of obesity later in life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Mother to infant born full term \> 37 weeks, and are under 1 month of age
- • Infant is singleton
- • Infant has no identified health problems
- • Infant is patient of CommUnityCare
- • Mother is 18 years of age
- • Mother is Latino/Hispanic ethnicity
- • Mother is willing to commit to study follow-up visits
- Exclusion Criteria:
- • Mother smokes
- • Mother works primarily at night
- • Infant has metabolic or chromosomal disorders, chronic neurological or respiratory conditions, or developmental disability
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Megan J Gray, MD,MPH,FAAP
Principal Investigator
University of Texas at Austin - Dell Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported